Skip to content

Ayurvedic formulations for knee osteoarthritis

Development& Clinical Evaluation of Polyherbal Formulation (capsule and oil)in Arthritis.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/07/001869
Enrollment
19
Registered
2011-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- osteoarthritis

Interventions

Intervention1: Polyherbal formulation (capsule) and Oil which consist of mustard oil with herb extract: 2 capsule 2 times in a day.(430 mg) oil applied once time in a day. duration:3 month The capsul

Sponsors

APMC COLLEGE OF PHARMACEUTICAL EDUCATION AND RESEARCH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients had clinical symptoms of knee osteoarthritis for at least 1 month prior to the study and suffering from mild to severe knee pain (with or without morning stiffness of 30 minutes duration).These patients had radiological evidence of osteophytes with findings like marginal lipping ,narrowing of joint space,osteoporosis.

Exclusion criteria

Exclusion criteria: patients with establishbed hypertension ,renal,hepatic or cardiac failure ,patients on long term corticosteroid treatment ,patients with biochemical and clinical evidence of Rheumatoid arthritis or gout and those who were unwilling to give informed consent form were excludedd from the study

Design outcomes

Primary

MeasureTime frame
normal functioning of knee Interms of Severity of pain, Joint swelling,Muscle rubbing, Morning stiffness, Difficulty in climbing steps, No. of joints involved, Joint spaceTimepoint: February 2011 to may 2011

Secondary

MeasureTime frame
To see the safety and efficacy of formulations in knee osteoarthritis patients.Timepoint: During february 2011 to May 2011

Countries

India

Contacts

Public ContactDr Bhupesh A Patel
drbhupesh23apr@yahoo.com9428027957

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026